Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The Children Liver Disease Research and Education Network (ChiLDREN) is conducting a clinical
trial to determine the feasibility, acceptability, tolerability and safety profile of IVIG
treatment administered to infants after hepatic portoenterostomy (HPE) for biliary atresia,
as well as investigate preliminary evidence of activity and explore mechanisms of action.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)